Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.

Houssein H AyoubHiam ChemaitellyMonia MakhoulZaina Al KanaaniEinas Al KuwariAdeel A ButtPeter CoyleAndrew JeremijenkoAnvar Hassan KaleeckalAli Nizar LatifRiyazuddin Mohammad ShaikHanan F Abdul RahimGheyath K NasrallahHadi M YassineMohamed G Al KuwariHamad Eid Al RomaihiMohamed H Al-ThaniRoberto BertolliniAbdullatif Al KhalLaith Jamal Abu-Raddad

Published in: BMJ innovations (2021)

Major health and economic gains can be achieved more quickly by prioritizing those who are antibody-negative while doses of the vaccine remain in short supply.

Keyphrases

sars cov
healthcare
public health
mental health
respiratory syndrome coronavirus
health information
climate change
human health